Absci (ABSI) Non-Current Assets (2020 - 2026)

Absci (ABSI) reported Non-Current Assets of $63.6 million for Q1 2026, down 16.8% on a YoY basis from $76.5 million in Q1 2025, and down 4.65% sequentially from $66.7 million in Q4 2025.

Absci (ABSI) Non-Current Assets (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Non-Current Assets data on file, last reported at $63.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 16.8% year-over-year to $63.6 million; the trailing twelve-month figure through Mar 2026 stood at $272.8 million (down 17.74% YoY), and the FY2025 full-year result was $66.7 million, down 16.36% from the prior year.
  • Non-Current Assets declined to $63.6 million in Q1 2026, from $66.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $139.5 million in Q1 2022 to a low of $63.6 million in Q1 2026.
  • A 5-year average of $99.0 million and a median of $93.1 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets declined 4.32% in 2022 and decreased 28.65% in 2024, its largest moves.
  • Tracing ABSI's Non-Current Assets over 5 years: stood at $134.1 million in 2022, then decreased by 27.9% to $96.7 million in 2023, then dropped by 17.52% to $79.8 million in 2024, then slipped by 16.36% to $66.7 million in 2025, then fell by 4.65% to $63.6 million in 2026.
  • Business Quant data shows ABSI's Non-Current Assets at $63.6 million in Q1 2026, $66.7 million in Q4 2025, and $70.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Absci 1.23 Bn 1.11 Bn - 63.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.62 Mn
Dec 31, 2025 66.72 Mn
Sep 30, 2025 70.00 Mn
Jun 30, 2025 72.49 Mn
Mar 31, 2025 76.47 Mn
Dec 31, 2024 79.78 Mn
Sep 30, 2024 85.09 Mn
Jun 30, 2024 90.34 Mn
Mar 31, 2024 93.10 Mn
Dec 31, 2023 96.72 Mn
Sep 30, 2023 101.63 Mn
Jun 30, 2023 106.12 Mn
Mar 31, 2023 130.49 Mn
Dec 31, 2022 134.15 Mn
Sep 30, 2022 138.01 Mn
Jun 30, 2022 138.43 Mn
Mar 31, 2022 139.50 Mn
Dec 31, 2021 153.12 Mn
Sep 30, 2021 148.45 Mn
Jun 30, 2021 144.68 Mn